Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure

被引:42
|
作者
Camilli, Romina [1 ]
D'Ambrosio, Fabio [1 ]
Del Grosso, Maria [1 ]
de Araujo, Fernanda Pimentel [1 ]
Caporali, Maria Grazia [1 ]
Del Manso, Martina [1 ]
Gherardi, Giovanni [2 ]
D'Ancona, Fortunato [1 ]
Pantosti, Annalisa [1 ]
机构
[1] Ist Super Sanita, Dept Infect Dis, Viale Regina Elena 299, I-00161 Rome, Italy
[2] Campus Biomed Univ, Dept Med, Rome, Italy
关键词
Streptococcus pneumoniae; IPD; Children; PCV7; PCV13; Antibiotic resistance; Pneumococcal clones; STREPTOCOCCUS-PNEUMONIAE; DRUG-RESISTANT; SEROTYPE; 19A; MENINGITIS; TRENDS; ERA; IMMUNIZATION; REDUCTION; 7-VALENT; INCREASE;
D O I
10.1016/j.vaccine.2017.07.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The use of PCV7 for children immunization was gradually implemented in the Italian regions starting from 2006 and was replaced by PCV13 in 2010-2011. In this study we aimed to assess the PCV impact on invasive pneumococcal diseases (IPD) incidence, serotype distribution and antibiotic resistance in Italian children under 5 years old. Methods: All IPD cases in children from 5 Italian regions (Emilia-Romagna, Lombardia, A. P. Bolzano, A. P. Trento, and Piemonte) reported through the nationwide surveillance system during 2008-2014 were included in this study. Pneumococcal isolates were subjected to serotyping, antibiotic susceptibility testing, and clonal analysis according to standard methods. Results: During the study period overall IPD incidence decreased from 7.8 cases/100,000 inhabitants in 2008 to 3.0 cases/100,000 in 2014 (61% decrease, P < 0.001). In particular, from 2008 to 2014, PCV7-type IPD decreased from 2.92 to 0.13 cases/100,000 inhabitants (95% decrease, P < 0.001) while PCV13-non-PCV7 type IPD decreased from 3.2 to 0.89 cases/100,000 inhabitants (72% decrease; P = 0.008). Results: Conversely, non-vaccine serotype (NVS) IPD increased overtime, becoming more common than PCV13 serotype IPD in 2013-2014. Emergent NVS 24F and 12F were the most prevalent in 2014. Antibiotic resistance testing revealed an overall increasing trend in penicillin resistance, from 14% in 2008 to 23% in 2014. Erythromycin resistance showed a downward trend, from 38% in 2008 to 27% in 2014. While in 2008 PCV13 serotypes were the major responsible for antibiotic resistance, during the following years antimicrobial resistance due to NVS increased, mainly as a result of expansion of preexisting clones. Conclusions: Both PCVs led to a substantial decrease in vaccine-related IPD incidence in the children population. However NVS-related IPD increased, becoming the most prevalent in the last two-years period. Continuous surveillance is an essential tool to monitor evolution of pneumococcal population causing IPD in children. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4587 / 4593
页数:7
相关论文
共 50 条
  • [1] The effects of pneumococcal conjugate vaccine (PCV7 and PCV13) on Turkish children with invasive pneumococcal disease: a single center experience
    Ozdemir, Halil
    Yildiz, Caner
    Otgun, Selin Nar
    Erkol, Hatice
    Karbuz, Adem
    Kocabas, Bilge Aldemir
    Kara, Tugce Tural
    Gozalan, Aysegul
    Durmaz, Riza
    Ciftci, Ergin
    Aysev, Derya
    Ince, Erdal
    [J]. ARCHIVOS ARGENTINOS DE PEDIATRIA, 2017, 115 (04): : 316 - 322
  • [2] Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases
    Rivera-Olivero, Ismar A.
    del Nogal, Berenice
    Fuentes, Mariana
    Cortez, Rossana
    Bogaert, Debby
    Hermans, Peter W. M.
    de Waard, Jacobus H.
    [J]. VACCINE, 2014, 32 (31) : 4006 - 4011
  • [3] Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany
    van der Linden, Mark
    Falkenhorst, Gerhard
    Perniciaro, Stephanie
    Fitzner, Christina
    Imoehl, Matthias
    [J]. PLOS ONE, 2016, 11 (08):
  • [4] Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska
    Bruce, Michael G.
    Singleton, Rosalyn
    Bulkow, Lisa
    Rudolph, Karen
    Zulz, Tammy
    Gounder, Prabhu
    Hurlburt, Debby
    Bruden, Dana
    Hennessy, Thomas
    [J]. VACCINE, 2015, 33 (38) : 4813 - 4819
  • [5] Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
    Galanis, Ilias
    Lindstrand, Ann
    Darenberg, Jessica
    Browall, Sarah
    Nannapaneni, Priyanka
    Sjostrom, Karin
    Morfeldt, Eva
    Naucler, Pontus
    Blennow, Margareta
    Ortqvist, Ake
    Henriques-Normark, Birgitta
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (04) : 1208 - 1218
  • [6] 13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): A phase 3, open-label trial
    Silfverdal, Sven Arne
    Flodmark, Carl-Erik
    Rombo, Lars
    Tansey, Susan P.
    Sidhu, Mohinder
    Trammel, James
    Emini, Emilio A.
    Gruber, William C.
    Scott, Daniel A.
    Gurtman, Alejandra
    [J]. VACCINE, 2013, 31 (09) : 1284 - 1292
  • [7] Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
    Tomczyk, Sara
    Lessa, Fernanda C.
    Sanchez, Jacqueline
    Pena, Chabela
    Fernandez, Josefina
    Carvalho, M. Gloria
    Pimenta, Fabiana
    Cedano, Doraliza
    Whitney, Cynthia G.
    Verani, Jennifer R.
    Coradin, Hilma
    Garib, Zacarias
    De Oliveira, Lucia Helena
    Feris-Iglesias, Jesus
    [J]. BMC INFECTIOUS DISEASES, 2018, 18
  • [8] Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
    Sara Tomczyk
    Fernanda C. Lessa
    Jacqueline Sánchez
    Chabela Peña
    Josefina Fernández
    M. Gloria Carvalho
    Fabiana Pimenta
    Doraliza Cedano
    Cynthia G. Whitney
    Jennifer R. Verani
    Hilma Coradin
    Zacarías Garib
    Lucia Helena De Oliveira
    Jesús Feris-Iglesias
    [J]. BMC Infectious Diseases, 18
  • [9] 13-valent pneumococcal conjugate vaccine (PCV13)
    Jefferies, Johanna M. C.
    Macdonald, Emily
    Faust, Saul N.
    Clarke, Stuart C.
    [J]. HUMAN VACCINES, 2011, 7 (10): : 1012 - 1018
  • [10] INVASIVE PNEUMOCOCCAL DISEASE IN ALASKAN CHILDREN: THE ROLE OF WATER SUPPLY AND THE SEVEN VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV7)
    Wenger, J. D.
    Zulz, T.
    Bruden, D.
    Bruce, M. G.
    Bulkow, L.
    Parks, D.
    Rudolph, K.
    Hurlburt, D.
    Singleton, R.
    Ritter, T.
    Klejka, J.
    Hennessy, T.
    [J]. INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2010, 69 : 100 - 100